Margarita Majem - Researcher Profile

Publications

2 shown

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst , Paul Baas , Dong‐Wan Kim +16 more

2015 The Lancet 6378 citations

Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer

Yi‐Long Wu , Masahiro Tsuboi , Jie He +21 more

In patients with stage IB to IIIA <i>EGFR</i> mutation-positive NSCLC, disease-free survival was significantly longer among those who received osimertinib than among those who r...

2020 New England Journal of Medicine 1609 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,987
Institution: Hospital de Sant Pau

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9919-7485

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.